Cardiovascular Risk Reduction: With the 2023 approval for reducing major adverse cardiovascular events, GLP-1 receptor agonists are now used within comprehensive cardiovascular risk-management strategies for patients with type 2 diabetes and established cardiovascular disease
Together, these forms of calcium help maintain bone strength, support healthy bone mineral content, and contribute to overall skeletal and dental health
Park JS, Nam JS, Cho MH, Yoo JS, Ahn CW, Jee SH, Lee HS, Cha BS, Kim KR, Lee HC
Amy Stobie, a marketing and communications expert whose experience spans FMCG, healthcare, pharmaceuticals, and vitamins, minerals and supplements (VMS), says Chinas Healthy China Initiative, launched in 2019 makes it well-prepared to support citizens who are prescribed GLP-1s for weight loss